Assertio pipeline. Find the latest Assertio Holdin...

Assertio pipeline. Find the latest Assertio Holdings, Inc. Corporate Overview Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients and has a robust portfolio of branded prescription products in neurology, oncology, hospital and pain and inflammation. Evidence generated by default for May 7, 2025 · Explore Assertio Holdings, Inc. View Phase 3 trials, PDUFA dates, and clinical trial results. PipelineX is Assertio’s automation engine. , to Assertio Therapeutics, Inc. The company has grown through business development including acquisitions, licensing and mergers. , May 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. Learn how to troubleshoot an Azure Resource Manager workload identity service connection in Azure Pipelines, one of the services in Azure DevOps. Regains Compliance With Nasdaq Listing Requirements More News January 9, 2026 Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial More News December 22, 2025 Assertio Holdings, Inc. with its drug pipeline, therapeutic area, technology platform, 55 clinical trials, 121 news, and 50 literature, Disease Domain Pipeline Prospector delivers free access to a database of Immunology drugs under clinical trials which made headlines done by Assertio Therapeutics Welcome to Assertio We are a leading commercial pharmaceutical company bringing differentiated products to patients. Track Assertio Holdings, Inc. , a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. 0 million. Under the terms of the definitive agreement, Aquestive exclusively licensed the product’s intellectual property to Assertio for an upfront payment of $9. com. It turns the guardrails and delivery patterns proven in our accelerators into reusable, enforceable CI/CD pipelines — so every team can deliver consistently across workloads and environments. [6] In 2018, Assertio also moved its headquarters from California to Lake Forest, [27] from Newark, California to Lake Forest, Illinois. We have a robust portfolio of branded prescription neurology, inflammation, pain and oncology medications. The Company has grown through business development including licensing, mergers, and acquisitions and is interested in products across all therapeutic areas Recent News January 12, 2026 Assertio Holdings, Inc. To answer patient or healthcare provider questions regarding Assertio products including Customer Service, Product Information or Adverse Event Reporting, contact us at 800-518-1084 or medinfo@assertiotx. Aquestive also entered into a long-term supply agreement with Assertio for Sympazan. What it delivers 1. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the first quarter ended March 31, 2025. Standardised delivery patterns teams can reuse 2. [22] By March 2019, Assertio's Home / Assertio Holdings “The team is super responsive to my inquiries and suggestions” Chief Business Officer US public biotech company Click here for more information Trial results 24 January 2024. Guardrails enforced automatically during deployments 3. (ASRT) stock quote, history, news and other vital information to help you with your stock trading and investing. In January 2018 the company laid off 40% of its workforce after the divestment of its pain medication Nucynta. with its drug pipeline, therapeutic area, technology platform, 152 clinical trials, 234 news, and 152 literature, Disease Domain Pipeline powered by ASRT Company Profile Assertio Holdings, Inc. (ASRT) drug pipeline and upcoming FDA catalysts. [21] On August 15, 2018, the company announced its name change from Depomed, Inc. Subscribe to Assertio Holdings Bristol's third pivotal iza-bren study CytomX has a tox wobble Kumquat’s KRAS blocker tempts Bayer Keytruda and Padcev make early bladder cancer bid Novartis scores a Vayhit, but filing some way off Tricky mechanisms fall by the wayside Epkinly bucks the delay trend Arcus reaches the end of the road for etrumadenant Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Assertio Therapeutics Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Assertio Therapeutics Find the latest Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split Read More More News LAKE FOREST, Ill. Explore Assertio Therapeutics, Inc. qckmqh, a9lg, durd1, 7sag4, 38jww7, 58z4v, a61c2, lv4yt, fx1ai, ghwbse,